CMV IgG/IgM Rapid Test (WB/S/P)

The CMV IgG/IgM Rapid Test is an antibody-based rapid test used to detect immune response against cytomegalovirus. CMV IgG usually suggests past exposure or previous infection, while CMV IgM may suggest recent infection, reactivation, or secondary infection.

• Cytomegalovirus, commonly known as CMV, is a common virus that can infect people of all ages.
• CMV infection is often mild or without symptoms in healthy people, but it can be important in pregnancy, newborn care, transplant evaluation, and immunocompromised patient assessment.
• CMV IgG testing may help identify past exposure or immune history.
• CMV IgM testing may support recent infection screening, but it should not be used alone for final diagnosis.

The CMV IgG/IgM Rapid Test by LARKSOIS Pharma may be used in professional ToRCH, infectious disease, and clinical screening environments.

Applications

• ToRCH screening support
• Pregnancy-related screening support
• Hospitals and diagnostic laboratories
• Gynecology and antenatal care settings
• Transplant evaluation support
• Immunocompromised patient assessment
• Infectious disease screening programs
• Professional point-of-care testing
• International diagnostic distribution

• The CMV IgG/IgM Rapid Test works on lateral flow immunochromatographic assay technology.
• When the sample is applied to the test device, it migrates across the membrane by capillary action.
• If CMV-specific IgG or IgM antibodies are present, they bind with coated CMV antigens and produce visible test lines.
• The test generally includes IgG line, IgM line, and control line for valid test performance.

The CMV IgG/IgM Rapid Test uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of Cytomegalovirus IgG and IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Detects CMV IgG antibodies
• Detects CMV IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Useful for ToRCH-related screening support
• Suitable for hospitals, labs, and distributors

The CMV IgG/IgM Rapid Test supports whole blood, serum, and plasma specimens. This flexibility makes the test practical for different clinical and laboratory workflows.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample area
• Add buffer according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The CMV IgG/IgM Rapid Test by LARKSOIS Pharma is designed for qualitative detection and differentiation of Cytomegalovirus IgG and IgM antibodies in whole blood, serum, or plasma specimens.

• CMV IgG positive usually suggests past CMV exposure or previous infection.
• CMV IgM positive may suggest recent infection, reactivation, or secondary infection.
• CMV IgM should not be used alone for final diagnosis and may require additional laboratory evaluation.
• Results should be interpreted with pregnancy status, immune status, symptoms, clinical history, and confirmatory testing when required.

The CMV IgG/IgM Rapid Test is a professional screening aid and should not be used as the only basis for diagnosis, pregnancy-related clinical decisions, transplant decisions, or treatment decisions.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• CMV IgM should not be used alone for final diagnosis
• Clinical evaluation and confirmatory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects Cytomegalovirus IgG antibodies
• Detects Cytomegalovirus IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Useful for ToRCH-related screening support
• International-quality diagnostic product from LARKSOIS Pharma

Note

The CMV IgG/IgM Rapid Test by LARKSOIS Pharma is designed for fast, practical, and accessible cytomegalovirus antibody screening support.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test device on a clean and flat surface
• Add whole blood, serum, or plasma to the sample area
• Add buffer according to the product insert
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

CMV IgG positive usually suggests past CMV exposure or previous infection. CMV IgM positive may suggest recent infection, reactivation, or secondary infection and should be interpreted with clinical history and follow-up testing.

Negative

A negative result means CMV IgG/IgM antibodies were not detected at the test’s detectable level.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device.

Instructions

• Store the CMV IgG/IgM Rapid Test according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides internationally suitable diagnostic products for hospitals, laboratories, clinics, healthcare distributors, and procurement agencies. The CMV IgG/IgM Rapid Test (WB/S/P) is designed for fast, practical, and accessible cytomegalovirus antibody screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable CMV IgG/IgM antibody screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible ToRCH screening solution